| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/14622416.8.8.933 |
| P698 | PubMed publication ID | 17716228 |
| P50 | author | John Ioannidis | Q6251482 |
| Despina Contopoulos-Ioannidis | Q29870901 | ||
| Ioanna N Kouri | Q114411402 | ||
| P2860 | cites work | Why most published research findings are false | Q21092395 |
| Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature | Q21563436 | ||
| Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing | Q24561362 | ||
| A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity | Q24650037 | ||
| T-bet polymorphisms are associated with asthma and airway hyperresponsiveness | Q24650376 | ||
| Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics | Q25257368 | ||
| Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness | Q28214089 | ||
| Replication validity of genetic association studies | Q29615456 | ||
| Genome-wide association studies for common diseases and complex traits | Q29615822 | ||
| Assessing the probability that a positive report is false: an approach for molecular epidemiology studies | Q29616285 | ||
| Concordance of functional in vitro data and epidemiological associations in complex disease genetics | Q31061331 | ||
| ADAM33 haplotypes are associated with asthma in a large Australian population | Q33246734 | ||
| The publication process itself was the major cause of publication bias in genetic epidemiology | Q33263359 | ||
| ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study | Q33278280 | ||
| The IL12B gene is associated with asthma | Q33910222 | ||
| The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma | Q33910403 | ||
| Recent developments in genomewide association scans: a workshop summary and review | Q34021104 | ||
| Heterogeneity of therapeutic responses in asthma | Q34255472 | ||
| The SERPINE2 gene is associated with chronic obstructive pulmonary disease | Q34398902 | ||
| Gene-environment interactions in human diseases | Q34407923 | ||
| Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways. | Q34416890 | ||
| Genome-wide association studies: theoretical and practical concerns | Q34555195 | ||
| The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis | Q34569981 | ||
| Genetic associations in large versus small studies: an empirical assessment | Q35070873 | ||
| Genetic associations: false or true? | Q35119636 | ||
| Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism | Q35534065 | ||
| Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers | Q35536131 | ||
| Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol | Q35536841 | ||
| Contribution of ADAM33 polymorphisms to the population risk of asthma | Q35537648 | ||
| Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype | Q35605536 | ||
| Mapping complex disease loci in whole-genome association studies | Q35784516 | ||
| Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype | Q35825639 | ||
| The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol | Q35825894 | ||
| Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. | Q36178971 | ||
| Genome-wide linkage analysis of pulmonary function in families of children with asthma in Costa Rica | Q36225605 | ||
| Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol | Q36237969 | ||
| Regular inhaled beta agonist in asthma: effects on exacerbations and lung function | Q36274606 | ||
| Beta 2 adrenergic receptor gene restriction fragment length polymorphism and bronchial asthma | Q36548352 | ||
| On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies | Q36689595 | ||
| The pharmacogenetics research network: from SNP discovery to clinical drug response. | Q36752662 | ||
| Non-replication and inconsistency in the genome-wide association setting | Q36841272 | ||
| IL10 gene polymorphisms are associated with asthma phenotypes in children | Q36995084 | ||
| Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study | Q37110324 | ||
| beta-Adrenergic receptor polymorphisms and response to salmeterol | Q37144386 | ||
| Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness | Q37248530 | ||
| Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations | Q37273821 | ||
| Genomewide screen for pulmonary function in 200 families ascertained for asthma | Q37282969 | ||
| Extended haplotype in the tumor necrosis factor gene cluster is associated with asthma and asthma-related phenotypes | Q37283048 | ||
| Comment on "A common genetic variant is associated with adult and childhood obesity" | Q37284957 | ||
| Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework | Q39428373 | ||
| Tests for interaction in epidemiologic studies: A review and a study of power | Q40164602 | ||
| Molecular evidence-based medicine: evolution and integration of information in the genomic era. | Q40219317 | ||
| Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium | Q40282176 | ||
| Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. | Q40812511 | ||
| Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients | Q42468185 | ||
| A road map for efficient and reliable human genome epidemiology | Q42680046 | ||
| Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma | Q43606071 | ||
| beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease | Q44079848 | ||
| Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma | Q44164884 | ||
| Chromosome 12q harbors multiple genetic loci related to asthma and asthma-related phenotypes | Q44545682 | ||
| Beta2-adrenergic receptor polymorphisms in African American children with status asthmaticus | Q44676714 | ||
| Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects | Q44834778 | ||
| Association of vitamin D receptor gene polymorphisms with childhood and adult asthma | Q44999167 | ||
| Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial | Q45121026 | ||
| The PTGDR gene is not associated with asthma in 3 ethnically diverse populations. | Q45943200 | ||
| CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma | Q46068802 | ||
| Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics | Q46129563 | ||
| ADAM33 polymorphisms and phenotype associations in childhood asthma | Q46200236 | ||
| Beta 2 adrenergic receptor polymorphisms in cystic fibrosis | Q46418612 | ||
| Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma | Q46565006 | ||
| Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*. | Q46590278 | ||
| Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene | Q46704679 | ||
| A common genetic variant is associated with adult and childhood obesity | Q46726890 | ||
| ALOX5 promoter genotype, asthma severity and LTC production by eosinophils | Q46858446 | ||
| ADAM33 is not associated with asthma in Puerto Rican or Mexican populations | Q46877836 | ||
| Influence of beta2-adrenergic receptor genotype on airway function during exercise in healthy adults | Q46990728 | ||
| The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). | Q47401096 | ||
| Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program | Q51697460 | ||
| Journals should publish all "null" results and should sparingly publish "positive" results | Q52998122 | ||
| Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases | Q53008274 | ||
| The Emergence of Networks in Human Genome Epidemiology | Q56828411 | ||
| Comment on "A Common Genetic Variant Is Associated with Adult and Childhood Obesity" | Q57249755 | ||
| A common coding variant in CASP8 is associated with breast cancer risk | Q57250674 | ||
| Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease | Q57253805 | ||
| Polymorphisms in Toll-Like Receptor 4 Are Not Associated with Asthma or Atopy-related Phenotypes | Q57253880 | ||
| β2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study | Q57416122 | ||
| β2-Adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma☆☆☆★★★ | Q57416148 | ||
| Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics | Q57416150 | ||
| Eotaxin polymorphisms and serum total IgE levels in children with asthma | Q58033504 | ||
| Family-based association analysis of β2-adrenergic receptor polymorphisms in the childhood asthma management program | Q58033532 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 933-958 | |
| P577 | publication date | 2007-08-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Pharmacogenomics | Q15724625 |
| P1476 | title | Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field | |
| P478 | volume | 8 |
| Q28266158 | Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain |
| Q44357874 | NAVAGATE: A Rubric to Move from Pharmacogenomics Science to Pharmacogenomics Practice |
| Q31144283 | Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment |
| Q35559008 | beta(2)-adrenergic receptor promoter haplotype influences spirometric response during an acute asthma exacerbation. |
Search more.